Full Day of Testimony in Fishman Trial

A New York jury heard a full day of testimony Jan. 21 in the horse doping trial of Dr. Seth Fishman and Lisa Giannelli. The entire morning and most of the afternoon featured a second day of testimony from a woman who worked for Fishman at his Florida business Equestology for five years.

Courtney Adams, 34, testifying from Florida via video conference, told jurors that Fishman and Equestology were all about “testability.” That meant creating “product” that couldn't be detected in post-race testing by horse racing authorities, she said.

During her testimony in U.S. District Court in Manhattan, prosecutors showed an email in which a veterinarian who was a client of Equestology asked about one of the products, equine growth hormone, and whether it was testable.

“That was our biggest selling point, that he specialized in making product that wasn't testable,” Adams testified, referring to Fishman.

The witness, who had been an Equestology office manager and then a sales rep, said that Fishman told her there was a risk of regulators coming up with a test to detect the substance. If that happened, Fishman said he would have to create another product that would be undetectable, she said.

“That was the whole point of that product to be not testable,” Adams testified.

Fishman and Giannelli face conspiracy charges in a wide-ranging scheme to dope horses with performance-enhancing drugs to boost the treated horses' chances of winning races. Those charged include prominent trainer Jason Servis, who has maintained a not guilty plea and is awaiting trial. Others, such as trainer Jorge Navarro, have pled guilty and been sentenced.

Prosecutors say the accused were motivated by greed to win races and acted without regard to the welfare and safety of horses.

While on the stand, Adams admitted helping to mislabel products that Fishman created for clients around the country and in the United Arab Emirates. She said she also shipped vials of product without any labels.

Under questioning by prosecutor Andrew Adams, the witness said that she knew “in general terms” that some of those who purchased Fishman's drugs were horse trainers.

“He would discuss why they wanted them and why they were being used by them,” she testified.

“And did he say why they were being used by trainers?” the prosecutor asked.

“He said they were being used because they were untestable,” Adams replied.

The jury also heard the witness cite the names of some of the drugs Equestology sold.

Those products included Endurance, Bleeder, Hormone Therapy Pack, HP Bleeder Plus, and PSDS.

Adams testified that PSDS stood for Pain Shot Double Strength, describing it as a “double strength product for pain.”

She indicated she didn't know what the other substances were for.

Adams said she stopped working for Equestology in 2017.

“I was over it to be honest,” Adams testified. “I didn't want to do it anymore.”

As she left, Fishman asked her not to discuss their business with anyone, Adams noted.

“I said okay,” she said.

She said in 2018 investigators with the Food and Drug Administration approached her to ask about Fishman. She said she wasn't comfortable talking to them without a lawyer.

After Fishman, Giannelli, Servis, and about two dozen others connected to horse racing were indicted in March 2020 in the doping case, Adams said a friend sent her a link with a story about the arrests.

She said after reading it she contacted law enforcement.

“I read the story, and I realized they didn't have the whole story, and I felt obliged to give it to them,” Adams told the jury.

She said as a result of the information she provided, government lawyers offered her a non-prosecution agreement.

During cross-examination, Fishman's attorney Maurice Sercarz sought to suggest that Adams was motivated to contact law enforcement out of personal animosity against Fishman.

She admitted that before she left Equestology, Fishman had accused her of theft and using Equestology funds to purchase personal items.

She told Sercarz she was upset about those accusations “because they were false.”

During his cross-examination, Giannelli's attorney, Louis Fasulo, questioned Adams about whether she would work at a place that put horses in danger.

No was her response.

Adams also said she didn't think she was breaking the law when labeling products she said were mislabeled.

Toward the end of the day, Long Island retired Federal Bureau of Investigation agent Angela Jett took the stand to read from notes of an interview she conducted with Fishman in 2010.

Jett said she had interviewed Fishman as a potential government witness in a $190 million securities fraud case. That case involved a magnate named David Brooks and a body-armor company he owned on Long Island. Fishman worked for Brooks, an owner of Standardbred racehorses that competed in New York and elsewhere.

According to the notes, Fishman told Jett that he had supplied performance-enhancing drugs to Brooks, who administered them to horses before racing.

Brooks was found guilty in 2010 of charges connected to the fraud and died in prison while serving a 17-year prison sentence.

Under cross-examination by Sercarz, Jett acknowledged that her notes don't say whether Fishman learned of the doping at the time it occurred or “after the fact.”

He also pointed out that Jett's notes show that when Brooks asked Fishman to dope a horse, Fishman refused.

Fishman's admissions to Jett never led to charges.

The trial resumes Jan. 24.

The Thoroughbred industry's leading publications are working together to cover this key trial.

 

The post Full Day of Testimony in Fishman Trial appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Horse-Doping Trial: Former Fishman Employee Cites Non-Testable Products

A New York jury heard a full day of testimony Jan. 21 in the federal horse doping trial of Dr. Seth Fishman and Lisa Giannelli.

The entire morning and most of the afternoon featured a second day of testimony from a woman who worked for Fishman at his Florida business Equestology for five years.

Courtney Adams, 34, testifying from Florida via video conference, told jurors that Fishman and Equestology were all about “testability.” That meant creating “product” that couldn't be detected in post-race testing by horse racing authorities, she said.

During her testimony in U.S. District Court in Manhattan, prosecutors showed an email in which a veterinarian who was a client of Equestology asked about one of the products, equine growth hormone, and whether it was testable.

“That was our biggest selling point, that he specialized in making product that wasn't testable,” Adams testified, referring to Fishman.

The witness, who had been an Equestology office manager and then a sales rep, said that Fishman told her there was a risk of regulators coming up with a test to detect the substance. If that happened, Fishman said he would have to create another product that would be undetectable, she said.

“That was the whole point of that product to be not testable,” Adams testified.

Fishman and Giannelli face conspiracy charges in a wide-ranging scheme to dope horses with performance-enhancing drugs to boost the treated horses' chances of winning races. Those charged include prominent trainer Jason Servis, who has maintained a not guilty plea and is awaiting trial. Others, such as trainer Jorge Navarro, have pled guilty and been sentenced.

Prosecutors say the accused were motivated by greed to win races and acted without regard to the welfare and safety of horses.

While on the stand, Adams admitted helping to mislabel products that Fishman created for clients around the country and in the United Arab Emirates. She said she also shipped vials of product without any labels.

Under questioning by prosecutor Andrew Adams, the witness said that she knew “in general terms” that some of those who purchased Fishman's drugs were horse trainers.

“He would discuss why they wanted them and why they were being used by them,” she testified.

“And did he say why they were being used by trainers?” the prosecutor asked.

“He said they were being used because they were untestable,” Adams replied.

The jury also heard the witness cite the names of some of the drugs Equestology sold.

Those products included Endurance, Bleeder, Hormone Therapy Pack, HP Bleeder Plus, and PSDS.

Adams testified that PSDS stood for Pain Shot Double Strength, describing it as a “double strength product for pain.”

She indicated she didn't know what the other substances were for.

Adams said she stopped working for Equestology in 2017.

“I was over it to be honest,” Adams testified. “I didn't want to do it anymore.”

As she left, Fishman asked her not to discuss their business with anyone, Adams noted.

“I said okay,” she said.

She said in 2018 investigators with the Food and Drug Administration approached her to ask about Fishman. She said she wasn't comfortable talking to them without a lawyer.

After Fishman, Giannelli, Servis, and about two dozen others connected to horse racing were indicted in March 2020 in the doping case, Adams said a friend sent her a link with a story about the arrests.

She said after reading it she contacted law enforcement.

“I read the story, and I realized they didn't have the whole story, and I felt obliged to give it to them,” Adams told the jury.

She said as a result of the information she provided, government lawyers offered her a non-prosecution agreement.

During cross-examination, Fishman's attorney Maurice Sercarz sought to suggest that Adams was motivated to contact law enforcement out of personal animosity against Fishman.

She admitted that before she left Equestology, Fishman had accused her of theft and using Equestology funds to purchase personal items.

She told Sercarz she was upset about those accusations “because they were false.”

During his cross-examination, Giannelli's attorney, Louis Fasulo, questioned Adams about whether she would work at a place that put horses in danger.

No was her response.

Adams also said she didn't think she was breaking the law when labeling products she said were mislabeled.

Toward the end of the day, Long Island retired Federal Bureau of Investigation agent Angela Jett took the stand to read from notes of an interview she conducted with Fishman in 2010.

Jett said she had interviewed Fishman as a potential government witness in a $190 million securities fraud case. That case involved a magnate named David Brooks and a body-armor company he owned on Long Island. Fishman worked for Brooks, an owner of Standardbred racehorses that competed in New York and elsewhere.

According to the notes, Fishman told Jett that he had supplied performance-enhancing drugs to Brooks, who administered them to horses before racing.

Brooks was found guilty in 2010 of charges connected to the fraud and died in prison while serving a 17-year prison sentence.

Under cross-examination by Sercarz, Jett acknowledged that her notes don't say whether Fishman learned of the doping at the time it occurred or “after the fact.”

He also pointed out that Jett's notes show that when Brooks asked Fishman to dope a horse, Fishman refused.

Fishman's admissions to Jett never led to charges.

The trial resumes Jan. 24.

The Thoroughbred industry's leading publications are working together to cover this key trial.

The post Horse-Doping Trial: Former Fishman Employee Cites Non-Testable Products appeared first on Horse Racing News | Paulick Report.

Source of original post

Fishman, Feds Spar Over Admissibility of Evidence

Seth Fishman and federal prosecutors are at odds over what types of evidence and expert testimony will be admissible in court when the veterinarian who allegedly made and sold purportedly performance-enhancing drugs (PEDs) goes on trial in early 2022.

In the form of dueling motions filed by each party Dec. 1 in  United States District Court (Southern District of New York), the two sides sparred over whether a jury should hear a wide range of evidence that involves what the government is alleging as Fishman “specifically target[ing] clients in the racehorse industry” by “peddling dozens of new drugs that purported to have performance-enhancing effects on racehorses [in a manner] squarely focused on ensuring that [he and his] customers would not get caught doing so.”

Some of what the prosecution wants admissible dates back at least a decade and involves Fishman being investigated in 2012 in Delaware when a Standardbred died after being injected with one of his prescribed products, plus separate PED-related admissions Fishman made in a different investigation that resulted in the prosecution of then-prominent Standardbred breeder David Brooks, who was convicted in 2013 in a $200 million fraud and obstruction of justice case.

The two sides also took umbrage at each other's choices of veterinary “experts” who have been submitted on witness lists to testify on the safety, efficacy, and clinical pharmacology of the drugs Fishman is alleged to have misbranded, adulterated, and conspired to distribute to other racetrack-based defendants in America and abroad.

Some of the motions made by both sides Wednesday that asked the court to exclude evidence relate to aspects of the case that have already been raised in previous court documents.

But one bizarre new offshoot that Fishman's legal team doesn't want brought up in front of a jury concerns a wiretapped phone conversation in which Fishman is allegedly asked by a camel-racing client in the United Arab Emirates (UAE) if he can also produce a “Viagra for ladies” that could be covertly added to a woman's drink.

The government is asserting that in February 2018, an individual identified only as “Bengawi” who purportedly worked for the UAE's Scientific Centers & Presidential Camel Department “solicited Seth Fishman to distribute PEDs, and to create and distribute [an aphrodisiac that] 'can be added in juice, for example.'”

Prosecutors wrote in a Nov. 17 court filing that, “In the course of these communications, the contact provided Seth Fishman with a video of what appeared to be an individual spiking a woman's unattended drink. In response, Seth Fishman offered to make 'BI-AGRA,' which he described as “Female Viagra so strong it makes the woman bisexual.”

The government's intent in wanting this exchange admissible appears to be rooted in establishing a pattern of what substances Fishman was able or willing to produce for clients.

The defense is objecting to the admissibility of those wiretapped sex-drug communications on the grounds that “the allegation that 'Bengawi' solicited the defendant to 'create and distribute illegal drugs' is a conclusion of law without any basis in fact…. It is unclear whether the defendant was responding in a humorous vein; or even taking the request seriously. There is no indication that the defendant subsequently shipped a substance intended for this use.'”

But even if the judge ends up disallowing that portion of evidence, the feds appear to be armed with a solid base of other wiretapped evidence to try and establish “Fishman's overall intent in his drug design–to avoid testability while increasing performance.”

One such intercepted conversation disclosed by the government in Wednesday's filing is a Mar. 31, 2019, call in which Fishman allegedly explains to a foreign potential client what his business strategy is at his Florida firm, Equestology:

“I design programs for people. So, if you're somebody who's got a bunch of endurance horses and you know what you are doing–and that's why I technically only work with trainers that have a certain amount of horses or more, because it would make sense to do it…I mostly work in regenerative peptides, and I work in things that are not commercially available.

“Every now and then people will ask me to make products because they want to go sell them to people who really don't know what's going on. Mostly camel guys that are in the desert. I don't have to tell you how it is, right?…But, I can meet with you [in Dubai]. You can explain to me your needs and wants and I can tell you how there's things that I made for other people that are not exclusive to them.

“If you want your own exclusive stuff, I'll tell you how we go about doing it. The reason I say that certain people want exclusivity is because, obviously, if these horses are being tested and they have something that somebody else has and that person is irresponsible, then it becomes a problem for them,” the government's motion stated.

When the judge does, in fact, rule on the admissibility questions, the crux of the decision might come down to which veterinarians will be allowed to testify and what they will be allowed to say in front of jurors.

The feds are objecting to Fishman's choice of Clara Fenger as a witness to opine on the nature of the pharmaceuticals he sold. She previously worked as a veterinarian with the Kentucky Horse Racing Commission for 15 years and is currently the sole proprietor of a Kentucky-based company called Equine Integrated Medicine.

Fenger's name might be familiar to racetrackers who have followed other drug-related cases. Her curriculum vita states she has provided “expert testimony” in no fewer than 19 international, federal, and state jurisdictions involving criminal, civil and administrative cases.

Recently, Fenger's work has included testifying on behalf of trainer Bob Baffert when his legal team overturned the 2020 lidocaine disqualifications of Charlatan and Gamine in Arkansas. Fenger also was hired by Baffert this past summer to escort the urine sample of GI Kentucky Derby winner Medina Spirit (Protonico) when it was sent to New York for additional betamethasone-related testing.

The prosecution's objection to Fenger is “because none of Dr. Fenger's opinions are admissible…insofar as they are unsupported and not based on facts, data, reliable

principles, or specialized knowledge, and because they concern issues that will serve only to sow confusion and distract the jury.”

In turn, Fishman's legal team is objecting to the three veterinarians the government wants to call as “experts”: Jean Bowman, veterinary medical officer in the Division of Surveillance for the Food and Drug Administration (FDA); Diana Link, a veterinary medical officer at the FDA Center for Veterinary Medicine, and Cynthia Cole, the Director of the Racing Laboratory at the University of Florida who was responsible for the regimen of drug testing at the Florida Department of Pari-Mutuel Wagering.

“First, the Court should preclude testimony suggesting that the purpose of the statutory scheme is to ensure the well-being of the racehorses,” Fishman's counsel wrote in a memorandum accompanying the Dec. 1 motions.

“Second, the Court should preclude evidence regarding the 'safety and efficacy' of those products allegedly manufactured and distributed by Dr. Fishman. The defendant is not charged in the instant Indictment with crimes relating to the manufacture or distribution of substances that are unsafe for use by animals…Opinion evidence regarding the 'safety and efficacy' of Dr. Fishman's products is, therefore, not relevant to the issues at trial.”

Fishman is charged with two felony counts. In a separate court order signed Dec. 2 by the judge in the case, it was noted that his case (along with co-defendant Lisa Giannelli) received the first back-up slot on the court calendar to begin a trial Jan. 19, 2022.

The post Fishman, Feds Spar Over Admissibility of Evidence appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights